相关实验视频
Updated: May 31, 2025

04:50
An Acupoint Catgut-embedding Therapy for Treating Obesity
Published on: April 4, 2025
282
什么时候应该开始治疗甲状腺疾病中的肥胖症?
Edyta Sutkowska1, Michał Kisiel2, Agnieszka Zubkiewicz-Kucharska3
1Department of Clinical Physiotherapy and Rehabilitation, Faculty of Physiotherapy, Wroclaw Medical University, 50-367 Wroclaw, Poland.
Biomedicines
|January 25, 2025
概括
肥胖和甲状腺疾病经常一起发生. 减肥对甲状腺功能有积极的影响,建议与甲状腺治疗一起优先考虑体重管理.
科学领域:
- 内分泌学 在内分泌学.
- 代谢障碍 代谢障碍 代谢障碍
- 甲状腺学 甲状腺学
背景情况:
- 肥胖和甲状腺功能障碍很普遍,通常是并存的情况.
- 甲状腺功能低下会导致体脂肪增加,而体重指数 (BMI) 双向地影响甲状腺激素水平.
- 肥胖和甲状腺健康之间的相互作用需要全面了解它们之间的关系.
研究的目的:
- 审查当前关于肥胖和甲状腺疾病之间的关系的科学文献.
- 为了评估减肥对甲状腺功能的影响,甲状腺功能障碍的个体.
- 讨论治疗策略对治疗肥胖和甲状腺疾病同时存在的治疗策略的影响.
主要方法:
- 关于肥胖,体重指数 (BMI) 和甲状腺功能现有研究的文献综述.
- 对调查减肥干预措施对甲状腺激素影响的研究进行分析.
- 关于脂肪组织和甲状腺健康之间的双向关系的证据综合.
主要成果:
- 证据表明,脂肪组织减少和改善甲状腺功能之间存在显著的正相关性.
- 身体质量指数 (BMI) 和甲状腺激素之间的关系被证实是双向的.
- 研究表明,减肥可以导致甲状腺激素配置的有利变化.
结论:
- 推迟甲状腺功能障碍患者的减肥疗法,超出标准替代疗法,目前的证据不支持.
- 在治疗甲状腺功能障碍的早期阶段整合体重管理策略是有必要的.
- 优化体重可以成为管理患有同时存在肥胖和甲状腺疾病的患者的关键组成部分.
相关概念视频
Synthesis and Regulation of Thyroid Hormones
4.1K
Low blood levels of the thyroid hormones — triiodothyronine (T3) and thyroxine (T4) — signal the hypothalamus to release the thyrotropin-releasing hormone (TRH). TRH then reaches the pituitary gland and stimulates the release of thyroid-stimulating hormone(TSH) into the bloodstream.
Upon reaching the thyroid gland, TSH stimulates the follicular cells' active uptake of iodide ions from the blood. The ions diffuse to the apical surface of the cells and are oxidized to iodine. The...
Upon reaching the thyroid gland, TSH stimulates the follicular cells' active uptake of iodide ions from the blood. The ions diffuse to the apical surface of the cells and are oxidized to iodine. The...
4.1K
Obesity
371
The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in...
371
Functions of Thyroid Hormones
2.5K
The thyroid hormone (TH) plays a pivotal role in the intricate orchestration of physiological processes, exerting profound effects on development, metabolism, and homeostasis throughout different life stages.
TH is indispensable for the normal development and maturation of the skeletal, muscular, and nervous systems during fetal and childhood growth. It facilitates bone mineral turnover and regulates protein synthesis in developing tissues, contributing significantly to overall growth and...
TH is indispensable for the normal development and maturation of the skeletal, muscular, and nervous systems during fetal and childhood growth. It facilitates bone mineral turnover and regulates protein synthesis in developing tissues, contributing significantly to overall growth and...
2.5K
The Thyroid Gland
3.5K
The thyroid gland is a small, butterfly-shaped gland located in the neck and covers the anterior surface of the trachea. The gland has two lateral lobes connected by a thin tissue mass called the isthmus. Internally, each lobe comprises many small spherical structures known as thyroid follicles, surrounded by a network of blood vessels.
The follicles have a central cavity lined by simple cuboidal to squamous epithelial cells called follicular cells. These cells produce the glycoprotein...
The follicles have a central cavity lined by simple cuboidal to squamous epithelial cells called follicular cells. These cells produce the glycoprotein...
3.5K
Diabetes: Management and Pharmacotherapy
233
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
233
Oral Hypoglycemic Agents: Sulfonylureas
184
Sulfonylureas are oral hypoglycemic agents utilized in treating type 2 diabetes. They are characterized by their unique sulfonylurea chemical structure. The family of sulfonylureas is divided into generations. First-generation sulfonylureas, including tolbutamide (Orinase), chlorpropamide (Diabinese), and tolazamide (Tolinase), trigger insulin release from pancreatic β cells and enhance peripheral tissues' insulin sensitivity. The second-generation members, such as glipizide...
184

